Contributed by Xiaoliang Sunney Xie; received November 7, 2023; accepted November 10, 2023; reviewed by Michel Nussenzweig and Fusheng Wang Considering the high risk of breakthrough infections in ...
A cancer expert from Oxford is leading one of several major new trials exploring how myeloma develops and how it could be prevented.
Objective: To develop a hospital-wide protocol for emergent evaluation of patients with stroke-like symptoms who are receiving anti-amyloid monoclonal antibodies (Aβ immunotherapy). Background: Aβ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results